药物信息为COREG CR (carvedilol phosphate) Extended-release Capsules (GlaxoSmithKline): DESCRIPTION
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- CLINICAL TRIALS
- CONTRAINDICATIONS
- WARNINGS
- ADVERSE REACTIONS
- OVERDOSAGE
- HOW SUPPLIED
- STORAGE
- PATIENT INFORMATION LEAFLET
- 外部链接相关的COREG CR (carvedilol phosphate) Extended-release Capsules (GlaxoSmithKline)
Carvedilol phosphate is a nonselective β-adrenergic blocking agent with α1-blocking activity. It is (2RS)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy) ethyl]amino]propan-2-ol phosphate salt (1:1) hemihydrate. It is a racemic mixture with the following structure:

Carvedilol phosphate is a white to almost-white solid with a molecular weight of 513.5 (406.5 carvedilol free base) and a molecular formula of C24H26N2O4•H3PO4•1/2 H2O.
COREG CR is available for once-a-day administration as controlled-release oral capsules containing 10, 20, 40, or 80 mg carvedilol phosphate. -Inactive ingredients include crospovidone, hydrogenated castor oil, hydrogenated vegetable oil, magnesium stearate, methacrylic acid copolymers, microcrystalline cellulose, and povidone.
- Drug Information Provided by National Library of Medicine (NLM).
